Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
13 pending office actions • 6 art units • 12 examiners • 0 of 13 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
UNIVERSITE DE PARIS-SACLAY currently manages 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct art units, indicating some technical concentration within the broader biotech field. There are 3 distinct examiners assigned to these actions, providing multiple reviews of the university's patent applications. This structure allows for a variety of perspectives on the university's intellectual property.
AARON DUREL WARD is the busiest examiner for the portfolio, with 1 pending action. With 3 pending office actions and 3 distinct examiners, the university's current prosecution is split among several individuals. The presence of 2 distinct art units means that while the examiners are different, the procedural environment is limited to the specific groups within the USPTO. Managing 3 pending office actions across 2 distinct art units requires the university to be mindful of the specific examination standards in each unit.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (23%) |
| §103 only | 4 (31%) |
| §102 only | 1 (8%) |
| §112 only | 1 (8%) |
| Multi-statute (no §101) | 4 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, HOPE A | 2 | 67.7% | +43.1% |
| LIEW, ALEX KOK SOON | 1 | 87.6% | +7.2% |
| DE LEON DOMENECH, RAFAEL O | 1 | 87.9% | +10.9% |
| VARNDELL, ROSS E | 1 | 84.7% | +13.3% |
| GRANT, MICHAEL CHRISTOPHER | 1 | 21.8% | +7.4% |
| KAMM, JUDITH MARIE | 1 | 43.5% | +56.6% |
| HAUT, EVAN HARRISON | 1 | 57.1% | +0.0% |
| WOLDEMARYAM, ASSRES H | 1 | 82.4% | +12.8% |
| HOFFMAN, ALEXANDER JOSEPH | 1 | — | — |
| REGLAS, GEORGIANA C | 1 | 37.7% | +36.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19099359 | COMPUTER-IMPLEMENTED METHOD OF LIVER RESECTION PLANNING | LIEW, ALEX KOK SOON | — |
| 18995387 | VOLTAGE/CURRENT OR CURRENT/VOLTAGE CONVERSION SYSTEM | DE LEON DOMENECH, RAFAEL O | — |
| 18722116 | WIDE-FIELD-OF-VIEW STATIC LIDAR | WOLDEMARYAM, ASSRES H | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18008298 | Method for generating a decision support system and associated systems | BOSTWICK, SIDNEY VINCENT | 8d overdue |
| 18262523 | DETECTING BETA-LACTAMASE ENZYME ACTIVITY | REGLAS, GEORGIANA C | 5d overdue |
| 18698789 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | ROBINSON, HOPE A | 2d overdue |
| 18863355 | METHOD FOR PROCESSING 3D IMAGING DATA AND ASSISTING WITH PROGNOSIS OF CANCER | VARNDELL, ROSS E | — |
| 18906825 | METHOD AND SYSTEM FOR TESTING COGNITION BY PROCESSING THE REACTION OF A SUBJECT TO STIMULI | GRANT, MICHAEL CHRISTOPHER | — |
| 18799390 | NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS | KAMM, JUDITH MARIE | — |
| 18708619 | PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY | HOFFMAN, ALEXANDER JOSEPH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262523 | DETECTING BETA-LACTAMASE ENZYME ACTIVITY | REGLAS, GEORGIANA C | 5d overdue |
| 18698789 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | ROBINSON, HOPE A | 2d overdue |
| 18995387 | VOLTAGE/CURRENT OR CURRENT/VOLTAGE CONVERSION SYSTEM | DE LEON DOMENECH, RAFAEL O | — |
| 18863355 | METHOD FOR PROCESSING 3D IMAGING DATA AND ASSISTING WITH PROGNOSIS OF CANCER | VARNDELL, ROSS E | — |
| 18799390 | NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS | KAMM, JUDITH MARIE | — |
| 18722116 | WIDE-FIELD-OF-VIEW STATIC LIDAR | WOLDEMARYAM, ASSRES H | — |
| 18266282 | LYSOSOMAL ACID LIPASE VARIANTS AND USES THEREOF | ROBINSON, HOPE A | — |
| Art Unit | Apps |
|---|---|
| 1652 | 2 |
| 2838 | 1 |
| 2668 | 1 |
| 1651 | 1 |
| 2124 | 1 |
| 2800 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19099359 | COMPUTER-IMPLEMENTED METHOD OF LIVER RESECTION PLANNING | LIEW, ALEX KOK SOON | — | §103 | Non-Final OA | — | Pending | Jan 28, 2025 |
| 18995387 | VOLTAGE/CURRENT OR CURRENT/VOLTAGE CONVERSION SYSTEM | DE LEON DOMENECH, RAFAEL O | 2838 | §102 | Non-Final OA | — | Pending | Jan 16, 2025 |
| 18863355 | METHOD FOR PROCESSING 3D IMAGING DATA AND ASSISTING WITH PROGNOSIS OF CANCER | VARNDELL, ROSS E | 2668 | §103§112 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18906825 | METHOD AND SYSTEM FOR TESTING COGNITION BY PROCESSING THE REACTION OF A SUBJECT TO STIMULI | GRANT, MICHAEL CHRISTOPHER | — | §101§112 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18799390 | NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS | KAMM, JUDITH MARIE | — | §102§103§112Other | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18722587 | IMPROVED WIDE-FIELD-OF-VIEW LIDAR | HAUT, EVAN HARRISON | — | §103 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18722116 | WIDE-FIELD-OF-VIEW STATIC LIDAR | WOLDEMARYAM, ASSRES H | — | §103 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18708619 | PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY | HOFFMAN, ALEXANDER JOSEPH | — | §101§103§112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18698789 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | ROBINSON, HOPE A | 1652 | §103§112 | Final Rejection | 2d overdue | Pending | Apr 05, 2024 |
| 18262523 | DETECTING BETA-LACTAMASE ENZYME ACTIVITY | REGLAS, GEORGIANA C | 1651 | §102§103 | Final Rejection | 5d overdue | Pending | Jul 21, 2023 |
| 18266282 | LYSOSOMAL ACID LIPASE VARIANTS AND USES THEREOF | ROBINSON, HOPE A | 1652 | §112 | Final Rejection | — | Pending | Jun 09, 2023 |
| 18008298 | Method for generating a decision support system and associated systems | BOSTWICK, SIDNEY VINCENT | 2124 | §101§103§112 | Non-Final OA | 8d overdue | Pending | Dec 05, 2022 |
| 17797292 | Device comprising a set of Josephson junctions, system comprising such a device and method for using such a device | NARAGHI, ALI | 2800 | §103 | Non-Final OA | — | Pending | Aug 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial